SE9502259D0 - Oligonucleotides to inhibit the expression of isoprenyl protein transferases - Google Patents

Oligonucleotides to inhibit the expression of isoprenyl protein transferases

Info

Publication number
SE9502259D0
SE9502259D0 SE9502259A SE9502259A SE9502259D0 SE 9502259 D0 SE9502259 D0 SE 9502259D0 SE 9502259 A SE9502259 A SE 9502259A SE 9502259 A SE9502259 A SE 9502259A SE 9502259 D0 SE9502259 D0 SE 9502259D0
Authority
SE
Sweden
Prior art keywords
oligonucleotides
inhibit
expression
protein transferases
isoprenyl protein
Prior art date
Application number
SE9502259A
Other languages
English (en)
Other versions
SE9502259L (sv
Inventor
Soudhir Colote
Eduardo Pirotzky
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE9502259D0 publication Critical patent/SE9502259D0/sv
Publication of SE9502259L publication Critical patent/SE9502259L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01029—Geranylgeranyl diphosphate synthase (2.5.1.29)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
SE9502259A 1994-06-29 1995-06-21 Oligonukleotider för att inhibera expression av isoprenylproteintransferas SE9502259L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9413035A GB9413035D0 (en) 1994-06-29 1994-06-29 Antisense oligonucleeotides

Publications (2)

Publication Number Publication Date
SE9502259D0 true SE9502259D0 (sv) 1995-06-21
SE9502259L SE9502259L (sv) 1995-12-30

Family

ID=10757497

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502259A SE9502259L (sv) 1994-06-29 1995-06-21 Oligonukleotider för att inhibera expression av isoprenylproteintransferas

Country Status (25)

Country Link
US (1) US5856461A (sv)
EP (1) EP0692535A1 (sv)
JP (1) JPH0851985A (sv)
KR (1) KR960000914A (sv)
CN (1) CN1124142A (sv)
AU (1) AU689887B2 (sv)
BR (1) BR9503015A (sv)
CA (1) CA2152233A1 (sv)
CZ (1) CZ291496B6 (sv)
DZ (1) DZ1903A1 (sv)
FI (1) FI953170A (sv)
FR (2) FR2721930B1 (sv)
GB (2) GB9413035D0 (sv)
HU (1) HU219823B (sv)
IE (1) IE950477A1 (sv)
MA (1) MA23595A1 (sv)
NO (1) NO952601L (sv)
NZ (1) NZ272398A (sv)
OA (1) OA10221A (sv)
PL (1) PL309384A1 (sv)
RU (1) RU2112766C1 (sv)
SE (1) SE9502259L (sv)
SK (1) SK83895A3 (sv)
TN (1) TNSN95068A1 (sv)
ZA (1) ZA955288B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002817A1 (en) * 1995-07-13 1997-01-30 University Of Cincinnati Compounds useful in the treatment of neurofibromatosis
CN1301731A (zh) * 1999-12-24 2001-07-04 上海博德基因开发有限公司 一种新的多肽——多异戊二烯基合成酶蛋白9和编码这种多肽的多核苷酸
WO2002046414A2 (en) * 2000-12-07 2002-06-13 Bristol-Myers Squibb Company Human g-protein coupled receptor expressed highly in kidney
US20030212017A1 (en) * 2002-05-10 2003-11-13 Isis Pharmaceuticals Inc. Antisense modulation of farnesyl transferase beta subunit expression
US7507808B2 (en) * 2002-12-12 2009-03-24 Isis Pharmaceuticals, Inc. Modulation of endothelial lipase expression
MXPA06002660A (es) * 2003-09-09 2006-09-04 Geron Corp Oligonucleotidos modificados para inhibicion de telomerasa.
US8785409B2 (en) * 2007-01-30 2014-07-22 Geron Corporation Compounds having anti-adhesive effects on cancer cells
JOP20200257A1 (ar) 2014-05-01 2017-06-16 Geron Corp تركيبات أوليجو نوكليوتيد وطرق لتحضيرها

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571421A (en) * 1979-11-05 1986-02-18 Genentech, Inc. Mammalian gene for microbial expression
US5004803A (en) * 1988-11-14 1991-04-02 Genetics Institute, Inc. Production of procoagulant proteins
US5420245A (en) * 1990-04-18 1995-05-30 Board Of Regents, The University Of Texas Tetrapeptide-based inhibitors of farnesyl transferase
US5185248A (en) * 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
ATE247163T1 (de) * 1991-03-07 2003-08-15 Virogenetics Corp Gentechnologisch hergestellter stamm für impfstoffe
NZ244820A (en) * 1991-10-25 1994-01-26 Isis Pharmaceuticals Inc Oligonucleotide inhibitor of epstein-barr virus.
US5348853A (en) * 1991-12-16 1994-09-20 Biotronics Corporation Method for reducing non-specific priming in DNA amplification
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA

Also Published As

Publication number Publication date
FI953170A (sv) 1995-12-30
RU2112766C1 (ru) 1998-06-10
AU689887B2 (en) 1998-04-09
ZA955288B (en) 1996-01-31
FR2721930A1 (fr) 1996-01-05
AU2329995A (en) 1996-01-11
SK83895A3 (en) 1996-05-08
OA10221A (fr) 1997-09-19
PL309384A1 (en) 1996-01-08
SE9502259L (sv) 1995-12-30
BR9503015A (pt) 1996-06-04
HUT72133A (en) 1996-03-28
FR2721827A1 (fr) 1996-01-05
FR2721930B1 (fr) 1997-01-03
KR960000914A (ko) 1996-01-25
NO952601D0 (no) 1995-06-28
HU9501913D0 (en) 1995-08-28
CZ168895A3 (en) 1996-05-15
MA23595A1 (fr) 1995-12-31
GB9413035D0 (en) 1994-08-17
GB2290791B (en) 1998-08-05
CZ291496B6 (cs) 2003-03-12
TNSN95068A1 (fr) 1996-02-06
FI953170A0 (sv) 1995-06-27
JPH0851985A (ja) 1996-02-27
IE950477A1 (en) 1996-01-10
NO952601L (no) 1996-01-02
NZ272398A (en) 1996-04-26
CN1124142A (zh) 1996-06-12
US5856461A (en) 1999-01-05
HU219823B (hu) 2001-08-28
EP0692535A1 (fr) 1996-01-17
CA2152233A1 (en) 1995-12-30
RU95110774A (ru) 1997-04-20
GB2290791A (en) 1996-01-10
GB9513246D0 (en) 1995-09-06
DZ1903A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
BR9810870A (pt) Regulação de expressão de quinolato fosforibosil transferase
RU95110871A (ru) Способы определения нуклеотидной последовательности
NO983716L (no) Metoksyetoksy oligonukleotider for modulering av protein-kinase C ekspresjon
NO985427L (no) Modulatorer for vevsregenerering
DK1250455T3 (da) Antisense-inhibering af PTP1B-ekspression
MXPA04000179A (es) Oligonucleotidos sinteticos de hebra doble para inhibicion especifica de expresion de gene.
RS49990B (sr) Dnk sekvence vezane za kukuruzni transformant pv-zmgt 32 (nk 603) i preparati i metode za njegovu detekciju
DE69331484D1 (de) N-Acetylglucosaminyl-Transferase, dafür kodierendes Gen, entsprechende Vektoren und transformierte Wirte und Herstellungsverfahren dafür
NO963860L (no) Isoprenyl-transferase-inhibitorer
BR0303093A (pt) Barras de limpeza contendo elementos discretos
DK0691980T3 (da) 7-deazapurinmodifiderende oligonukleotider
DK1123414T3 (da) Antisense-modulering af integrin alpha 4.ekspression
SE9502259D0 (sv) Oligonucleotides to inhibit the expression of isoprenyl protein transferases
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
PT775745E (pt) Aptameros inibidores de catepsina g
EP1268507A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF THE TRANSCRIPTION FACTOR E2F-1
WO1999014337A3 (en) New plant genes
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
DE69332375D1 (de) Hundecoronavirus s gen und verwendung davon
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
NO995948D0 (no) DNA-sekvenser, ekspresjon av disse DNA-sekvenser, termofile laccaser kodet for av DNA-sekvensene, samt anvendelse av disse
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
BR9803717A (pt) ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase.
HUP0300654A2 (hu) Eljárás fokozottan szárazságtűrő növények előállítására

Legal Events

Date Code Title Description
NAV Patent application has lapsed